share_log

HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $2 Price Target

Benzinga ·  Aug 11, 2023 06:46

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $2 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment